NeoVentures Biotechnology Europe partners with Ombion
NeoVentures Biotechnology Europe Partners with Ombion Biomarker discovery has been and remains a key to advancing treatments in healthcare. The
July 3, 2025
News
Read More »
NVB Europe has joined NVIDIA Inception
NeoVentures Biotechnology Europe has joined NVIDIA Inception, a program designed to help startups evolve faster through cutting-edge technology and access
January 7, 2025
Strategic Partnership with IRD-Montpellier
The Institut de Recherche pour le Développement, Délégation Régionale Occitanie (IRD-Montpellier), and NeoVentures Biotechnology Europe (NVBE) are proud to announce
December 16, 2024
Join us at BIO-Europe Spring 2024
NeoVentures Biotechnology Europe will be attending BIO-Europe Spring.
February 2, 2024
NeoNeuro partners with the INSIGHT cohort
NeoNeuro SAS has entered into a collaboration under the leadership of Professor Harald Hampel to work with the INSIGHT cohort for
November 10, 2017
NeoNeuro collaborates with the AIBL study
NeoNeuro SAS is pleased to announce a collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)
June 5, 2017
NeoNeuro awarded a new BPI France grant
NeoNeuro has received a new grant from BPIfrance Financement, CMI- Amorcage 2 to continue our research towards the development of
December 12, 2015
BPI France Grant
NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic
September 25, 2015